Bachem Holding AG (SWX: BANB)

Market Cap	5.95B
Revenue (ttm)	577.77M
Net Income (ttm)	113.57M
Shares Out	74.97M
EPS (ttm)	1.52
PE Ratio	52.34
Forward PE	47.02
Dividend	0.80 (1.01%)
Ex-Dividend Date	Apr 26, 2024

Volume	38,310
Open	77.90
Previous Close	79.35
Day's Range	76.80 - 79.10
52-Week Range	53.95 - 91.65
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2024

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,009
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BANB

Financial Performance

In 2023, FHZN's revenue was 1.24 billion, an increase of 20.79% compared to the previous year's 1.02 billion. Earnings were 304.20 million, an increase of 46.96%.